Head and neck cancer treatment is shifting decisively from radical resections and non-selective chemotherapies to precision immuno-oncology and organ-preserving care.
According to latest research by Maximize Market Research, the Global Head and Neck Cancer Market is projected to grow from $3.79B in 2025 to nearly $9.30B by 2034, advancing at a 10.5% CAGR.
Key clinical and market drivers:
Surging incidence of HPV-positive oropharyngeal cancers prompting tailored de-escalation protocols
Rapid ... moreHead and neck cancer treatment is shifting decisively from radical resections and non-selective chemotherapies to precision immuno-oncology and organ-preserving care.
According to latest research by Maximize Market Research, the Global Head and Neck Cancer Market is projected to grow from $3.79B in 2025 to nearly $9.30B by 2034, advancing at a 10.5% CAGR.
Key clinical and market drivers:
Surging incidence of HPV-positive oropharyngeal cancers prompting tailored de-escalation protocols
Rapid adoption of PD-1/PD-L1 checkpoint inhibitors, bispecifics, and next-gen EGFR targeted therapies
Earlier recurrence tracking powered by non-invasive liquid biopsies and ctDNA assays
How is your organization adapting pipelines to the convergence of molecular diagnostics and targeted biologics?
Posted by Surbhi on July 24 2026 at 05:41 PM
public
Setmelanotide (IMCIVREE) — the first FDA-approved melanocortin-4 receptor (MC4R) agonist specifically indicated for proopiomelanocortin (POMC) deficiency-associated obesity representing the targe...
Posted by Surbhi on July 23 2026 at 06:02 PM
public
Cell and gene therapy commercialization in next-generation biotherapeutics — the engineered living cell products and genetic medicines (CAR-T, gene editing, stem cell therapies) moving from clini...
Posted by Surbhi on July 14 2026 at 08:20 PM
public
Single-cell genome sequencing — the technologies enabling the analysis of genomic DNA, RNA, and epigenetic modifications at the individual cell level, resolving cellular heterogeneity invisible t...
Posted by Surbhi on July 14 2026 at 07:22 PM
public
Streptavidin kits — the biotin-binding protein reagent systems enabling high-affinity (Kd ~10^-15 M), versatile detection, purification, and conjugation across immunoassays, flow cytometry, micro...
